Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
Top Cited Papers
- 30 May 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 5 (4), 487-495
- https://doi.org/10.1021/mp800032f
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Nanoconjugate based on polymalic acid for tumor targetingChemico-Biological Interactions, 2008
- Novel function of complement C3d as an autologous helper T‐cell targetImmunology & Cell Biology, 2008
- Immunological properties of engineered nanomaterialsNature Nanotechnology, 2007
- Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing NanoparticlesBioconjugate Chemistry, 2007
- Water‐Soluble Carbosilane Dendrimers: Synthesis Biocompatibility and Complexation with Oligonucleotides; Evaluation for Medical ApplicationsChemistry – A European Journal, 2006
- PEG-modified gold nanorods with a stealth character for in vivo applicationsJournal of Controlled Release, 2006
- Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptakeJournal of Biomedical Materials Research Part A, 2006
- Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticlesBiomaterials, 2005
- Hemolytic Effects of Water-Soluble Fullerene DerivativesJournal of Medicinal Chemistry, 2004
- The role of complement in inflammation and phagocytosisImmunology Today, 1991